Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Magnesium for treating sickle cell disease.

Nan Nitra Than1, Htoo Htoo Kyaw Soe1, Senthil K Palaniappan2

  • 1Department of Community Medicine, Melaka-Manipal Medical College, Jalan Batu Hampar, Bukit Baru, Melaka, Malaysia, 75150.

The Cochrane Database of Systematic Reviews
|April 15, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EHA Recommendations for preconceptual and antenatal screening and prenatal diagnosis for hemoglobinopathies.

HemaSphere·2026
Same author

Exercise reveals precocious-subclinical cardiovascular and muscular dysfunction in transfusion dependent beta-thalassemia (TDT) patients without cardiac iron overload.

Journal of translational medicine·2026
Same author

Hematopoietic Stem Cell Transplantation for Hyperhemolytic Syndrome.

Pediatric blood & cancer·2026
Same author

Novel phosphatase-based regulatory loop for HbF expression.

Blood·2026
Same author

The Emerging Role of Liver Stiffness Measurement in Transfusion Dependent Thalassemia.

American journal of hematology·2026
Same author

Morphometric Analysis of Soft Palate: Comparison of Need's Ratio with Palatal Variants and Gender Using Digital Lateral Cephalogram in Normal Individuals.

Annals of African medicine·2026

Magnesium therapy, both intravenous and oral, did not significantly reduce painful crises, hospital stays, or improve quality of life for sickle cell disease patients. Further research is needed to confirm any clinical benefits of magnesium for this condition.

Area of Science:

  • Hematology
  • Pharmacology

Background:

  • Sickle cell disease (SCD) is a genetic disorder causing painful vaso-occlusive crises due to red blood cell dehydration.
  • Existing research suggests potential benefits of magnesium for SCD, but evidence is limited.
  • There is a need to evaluate magnesium's impact on pain frequency, hospital stay duration, and quality of life in SCD patients.

Purpose of the Study:

  • To assess the effects of short-term intravenous magnesium on hospital stay length and quality of life in individuals with SCD.
  • To determine the impact of long-term oral magnesium therapy on painful crisis frequency and quality of life in SCD patients.

Main Methods:

  • Searched the Cochrane Haemoglobinopathies Trials Register and clinical trials registries for randomized controlled studies.
  • Included five randomized placebo-controlled studies with 386 participants.

Related Experiment Videos

  • Assessed study quality and extracted data using standard Cochrane methodologies.

    • Main Results:

    • Two studies on intravenous magnesium (n=306) showed no significant difference in pain scores or quality of life, with low to moderate evidence quality.
    • One study reported no difference in length of hospital stay, while adverse events like infusion site warmth were noted.
    • Three studies on oral magnesium (n=80) yielded low-quality evidence, with no reported differences in painful days, quality of life, or hospital stay.

    Conclusions:

    • Current moderate to low quality evidence indicates that neither intravenous nor oral magnesium therapy effectively reduces painful crises, hospital stays, or improves quality of life in sickle cell disease.
    • No definitive conclusions can be drawn regarding the clinical benefits of magnesium for SCD.
    • Further multicenter randomized controlled trials are necessary to establish the efficacy of magnesium therapies in improving health outcomes for individuals with sickle cell disease.